Nestle, Mars Face Antitrust Suit Over Prescription Pet Food

Law360, Los Angeles (December 8, 2016, 5:25 PM EST) -- Mars, Nestle, PetSmart and others are accused of violating the Sherman Act for allegedly fixing the prices of prescription pet food that doesn't contain actual medicine, partially through the use of brand-owned clinics, according to a putative class action filed in California federal court on Wednesday.

The complaint says that PetSmart, three pet food manufacturers and two veterinary clinic chains colluded to fix prices on four brands of prescription pet food that have trumped up health benefits, as they do not contain a drug but require prescription authorization. The consumer complaint also says Mars Petcare USA Inc.'s majority ownership of Banfield...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!